Wyoming Tech Reporter
SEE OTHER BRANDS

Your best source on science and technology news from Wyoming

Wyoming Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Tech Reporter.

Press releases published on July 24, 2025

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro™ at the Alzheimer’s Association International Conference

Boca Raton, July 24, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) announced today that additional analyses from its Phase 2 MINDFuL trial evaluating XPro™, a novel selective soluble TNF inhibitor, will be released in an oral presentation at the …

Xtract One Secures SmartGateway Contract with Global Performing Arts Company Famous for Live Entertainment

Xtract One Secures SmartGateway Contract with Global Performing Arts Company Famous for Live Entertainment

TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway screening solution has been chosen by a leading, global performing arts company, known …

TCG Labs Soleil Raises an Additional $400 Million and Expands Global R&D Capabilities

TCG Labs Soleil Raises an Additional $400 Million and Expands Global R&D Capabilities

SAN FRANCISCO, July 24, 2025 (GLOBE NEWSWIRE) -- TCG Labs Soleil, a venture firm integrating dedicated capital with an in-house biotech R…

Biomea Fusion Appoints Julianne Averill to its Board of Directors

Biomea Fusion Appoints Julianne Averill to its Board of Directors

SAN CARLOS, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea,” “Biomea Fusion” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced the appointment of Julianne Averill to its Board …

Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy

Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy

Expedited Enrollment Surpassing 630 Targeted Participants Underscores the Strong Demand for a Therapy Focused on Vision Preservation Phase 3 ARCHER II Trial Design and Rationale to Be Presented at ASRS, a Leading Meeting for Retina Science and Innovation …

MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler

MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler

TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specializing in precision-based cannabinoids, is pleased to announce it has …

DebitMyData Closes Oversubscribed Seed Round- Launches $1B Human Energy Grid Global Expansion

DebitMyData Closes Oversubscribed Seed Round- Launches $1B Human Energy Grid Global Expansion

DebitMyData™ Logo FORT LAUDERDALE, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- DebitMyData™, Inc.—the powerhouse has closed a seed round at more than twice its original target. This surge of investor confidence paves the way for a bold, billion-dollar global …

MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials

MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials

LA JOLLA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), today provides an …

Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025

Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025

LOUISVILLE, Colo., July 24, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the second quarter ended June 30, 2025 after the close of trading on …

CLEAR, an Official TSA PreCheck® Enrollment Provider, Expands Enrollment and Renewal Options by Opening a New Location at Aventura Mall in South Florida

CLEAR, an Official TSA PreCheck® Enrollment Provider, Expands Enrollment and Renewal Options by Opening a New Location at Aventura Mall in South Florida

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), an authorized TSA PreCheck® enrollment provider, continues to expand locations outside the airport environment to enroll and renew consumers in the Trusted Traveler program by opening a new …

Nano Labs Appoints Ms. Can Yang as Senior Vice President of Subsidiary Nano bit to Oversee Execution of Digital Currency Strategic Reserves and Strengthen BNB Reserve Capabilities

Nano Labs Appoints Ms. Can Yang as Senior Vice President of Subsidiary Nano bit to Oversee Execution of Digital Currency Strategic Reserves and Strengthen BNB Reserve Capabilities

HONG KONG, July 24, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider in China, today announced the appointment of Ms. Can Yang as senior vice president …

SALTGATOR Debuts Desktop Soft-Gel Injection Machine on Kickstarter — A Game-Changer for Makers

SALTGATOR Debuts Desktop Soft-Gel Injection Machine on Kickstarter — A Game-Changer for Makers

DICKINSON, Texas, July 24, 2025 (GLOBE NEWSWIRE) -- SALTGATOR Tech Inc., an Dickinson-based startup dedicated to accessible fabrication tools, is proud to announce the launch of its Kickstarter campaign for the SALTGATOR — the world’s first desktop soft- …

Aicuris Enrolled Last Participant in Pivotal Trial with Pritelivir to Treat Refractory Herpes Simplex Infection in Immunocompromised Patients

Aicuris Enrolled Last Participant in Pivotal Trial with Pritelivir to Treat Refractory Herpes Simplex Infection in Immunocompromised Patients

Wuppertal, Germany, July 24, 2025 - Aicuris Anti-infective Cures AG today announced the completion of patient enrollment in its pivotal Phase 3 trial, PRIOH-1, evaluating pritelivir for the treatment of refractory and/or treatment resistant herpes simplex …

Aurora Mobile CEO Comments on Robinhood CEO's Crypto Remarks

Aurora Mobile CEO Comments on Robinhood CEO's Crypto Remarks

SHENZHEN, China, July 24, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today issued a statement from its CEO, Mr. Luo …

Aptean Launches GenAI Query in AppCentral

Aptean Launches GenAI Query in AppCentral

ATLANTA, July 24, 2025 (GLOBE NEWSWIRE) -- Aptean, a global provider of enterprise software, today announced the launch of GenAI Query, a mobile-first conversational intelligence feature within AppCentral, its AI-powered platform. Purpose-built to deliver …

Rhombus Expands AI-Powered Operational Analytics by Launching Line Crossing and Occupancy Counting

Rhombus Expands AI-Powered Operational Analytics by Launching Line Crossing and Occupancy Counting

SACRAMENTO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Rhombus, a leader in cloud-managed physical security solutions, today announced the expansion of its AI-powered Operational Analytics capabilities with two powerful new features: Line Crossing and …

First half of 2025: Solid growth, investments and pipeline progress pave the way for two key launches in H2

First half of 2025: Solid growth, investments and pipeline progress pave the way for two key launches in H2

Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion) Regulatory submissions underway for zongertinib and nerandomilast, with launches expected in H2 2025 Strategic investments in …

Citryll Announces Formation of Scientific Advisory Board

Citryll Announces Formation of Scientific Advisory Board

CITRYLL ANNOUNCES FORMATION OF SCIENTIFIC ADVISORY BOARD Board comprises world-renowned experts in biology, immunology and pathology Oss, Netherlands – 24 July 2025 – Citryll, a biotech company pioneering a transformative approach to treating immune- …

AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS

AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS

PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM SEVERAL EUROPEAN COUNTRIES TO INITIATE THE CONFIRMATORY PHASE 3 STUDY OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS THIS APPROVAL FOLLOWS PROTOCOL VALIDATION BY THE EMA AND FDA AUTHORIZATION Paris, July …

AB Science a obtenu l'autorisation de plusieurs pays européens pour initier l’étude confirmatoire de phase 3 avec le masitinib dans la SLA

AB Science a obtenu l'autorisation de plusieurs pays européens pour initier l’étude confirmatoire de phase 3 avec le masitinib dans la SLA

COMMUNIQUÉ DE PRESSE AB SCIENCE A OBTENU L'AUTORISATION DE PLUSIEURS PAYS EUROPÉENS POUR INITIER L’ETUDE CONFIRMATOIRE DE PHASE 3 AVEC LE MASITINIB DANS LA SCLEROSE LATERALE AMYOTROPHIQUE CETTE AUTORISATION FAIT SUITE A LA VALIDATION DU PROTOCOLE PAR L’EMA …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions